Jafron Biomedical Co.,Ltd.’s Net Profit Dropped 51.6% in First Three Quarters of 2023

Jafron Biomedical Co.,Ltd. (健帆生物科技集团股份有限公司) (300529.SZ) reported a net profit of 420.4 million yuan in the first three quarters of 2023, down 51.6% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, down 26.6% year-on-year.

At the end of the reporting period, it had 5.5 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 43.2%.